Geode Capital Management
ENVB icon

Geode Capital Management’s Enveric Biosciences ENVB Stock Holding History

Geode Capital Management’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.4K Buy
+32,149
New +$87.7K ﹤0.01% 4262
2025
Q4 		– Sell
-2,376
Closed -$18.2K – 4497
2025
Q3 		$18.2K Buy
2,376
+29
+1% +$380 ﹤0.01% 4423
2025
Q2 		$34.1K Buy
2,347
+134
+6% +$2.03K ﹤0.01% 4283
2025
Q1 		$36.9K Buy
2,213
+1,010
+84% +$35K ﹤0.01% 4244
2024
Q4 		$77.6K Sell
1,203
-8
-0.7% -$581 ﹤0.01% 4159
2024
Q3 		$103K Buy
1,211
+963
+388% +$88.6K ﹤0.01% 4093
2024
Q2 		$27.7K Buy
248
+175
+240% +$26.4K ﹤0.01% 4400
2024
Q1 		$13.1K Hold
73
– – ﹤0.01% 4529
2023
Q4 		$17.1K Hold
73
– – ﹤0.01% 4538
2023
Q3 		$30.3K Buy
+73
New +$32.9K ﹤0.01% 4534
2022
Q3 		– Sell
-23
Closed -$43K – 5032
2022
Q2 		$43K Buy
23
+4
+21% +$8.51K ﹤0.01% 4808
2022
Q1 		$54K Hold
19
– – ﹤0.01% 4789
2021
Q4 		$154K Buy
19
+6
+46% +$84.3K ﹤0.01% 4588
2021
Q3 		$238K Buy
13
+2
+18% +$38.8K ﹤0.01% 4366
2021
Q2 		$235K Buy
11
+4
+57% +$85.7K ﹤0.01% 4274
2021
Q1 		$193K Buy
+7
New +$245K ﹤0.01% 4120
2020
Q4 		– Hold
0
– -$14K – 4276
2020
Q3 		– Hold
0
– – – 4134
2020
Q2 		– Hold
0
– – – 4078
2020
Q1 		– Hold
0
– – – 4080
2019
Q4 		– Hold
0
– – – 4140
2019
Q3 		– Hold
0
– – – 4075

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management's ENVB Position: Q1 2026 in Review

Geode Capital Management opened a new position in Enveric Biosciences (ENVB) in Q1 2026: 32,149 shares worth $62.4K. The stake represents ﹤0.01% of the portfolio and ranks #4262 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in ENVB as recently as Q3 2025.

Geode Capital Management first reported a position in ENVB in Q1 2021 and has held it in 16 quarters since. The position peaked at $238K in Q3 2021. 11 funds tracked by Wall St. Rank hold ENVB as of Q1 2026.

  • Geode Capital Management held 32,149 shares of Enveric Biosciences worth $62.4K as of Q1 2026.
  • Enveric Biosciences was a new Geode Capital Management position in Q1 2026.
  • Enveric Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4262 holding.
  • Geode Capital Management first reported a position in Enveric Biosciences in Q1 2021 and has held it in 16 quarters since.
  • Geode Capital Management's Enveric Biosciences position peaked at $238K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.